衰老关键蛋白1(FBLN1)重组蛋白
Recombinant Fibulin 1 (FBLN1)
- 编号RPC472Hu02
- 物种Homo sapiens (Human,人)相同的名称,不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量16.28kDa
- 实际分子量16kDa(差异分析请参阅说明书)
- 片段与标签Glu127~Arg241 with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点4.0
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 840 ¥ 2100¥ 4200¥ 12600¥ 31500
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列

用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPC472Hu02 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC472Hu03 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC472Hu01 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC472Hu02 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB |
PAC472Hu01 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB |
PAC472Hu03 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB |
FAC472Hu01 | 抗衰老关键蛋白1(FBLN1)多克隆抗体 | FCM |
FAC472Hu03 | 抗衰老关键蛋白1(FBLN1)多克隆抗体 | Flow cytometry. |
LAC472Hu71 | 衰老关键蛋白1(FBLN1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAC472Hu21 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC |
MAC472Hu22 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC |
FAC472Hu02 | 抗衰老关键蛋白1(FBLN1)单克隆抗体 | FCM |
LAC472Hu72 | 衰老关键蛋白1(FBLN1)单克隆抗体(生物素标记) | WB; IHC; ICC. |
SEC472Hu | 衰老关键蛋白1(FBLN1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCC472Hu | 衰老关键蛋白1(FBLN1)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMC472Hu | 衰老关键蛋白1(FBLN1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
PSC472Hu01 | 衰老关键蛋白1(FBLN1)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSC472Hu01 | 衰老关键蛋白1(FBLN1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Clin Exp Metastasis. | Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734] |
Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509] |
PROTEOMICS - Clinical Applications | Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients.[pubmed:26680509] |
ENVIRONMENTAL RESEARCH | Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421] |